You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

AVENTYL HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Aventyl Hydrochloride, and when can generic versions of Aventyl Hydrochloride launch?

Aventyl Hydrochloride is a drug marketed by Lilly and is included in one NDA.

The generic ingredient in AVENTYL HYDROCHLORIDE is nortriptyline hydrochloride. There are twelve drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the nortriptyline hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Aventyl Hydrochloride

A generic version of AVENTYL HYDROCHLORIDE was approved as nortriptyline hydrochloride by DR REDDYS LABS SA on March 30th, 1992.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for AVENTYL HYDROCHLORIDE?
  • What are the global sales for AVENTYL HYDROCHLORIDE?
  • What is Average Wholesale Price for AVENTYL HYDROCHLORIDE?
Summary for AVENTYL HYDROCHLORIDE
Drug patent expirations by year for AVENTYL HYDROCHLORIDE
Recent Clinical Trials for AVENTYL HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Central Michigan UniversityN/A
Sheppard Pratt Health SystemN/A

See all AVENTYL HYDROCHLORIDE clinical trials

US Patents and Regulatory Information for AVENTYL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly AVENTYL HYDROCHLORIDE nortriptyline hydrochloride CAPSULE;ORAL 014684-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lilly AVENTYL HYDROCHLORIDE nortriptyline hydrochloride CAPSULE;ORAL 014684-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for AVENTYL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lilly AVENTYL HYDROCHLORIDE nortriptyline hydrochloride CAPSULE;ORAL 014684-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Lilly AVENTYL HYDROCHLORIDE nortriptyline hydrochloride CAPSULE;ORAL 014684-002 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for AVENTYL HYDROCHLORIDE

See the table below for patents covering AVENTYL HYDROCHLORIDE around the world.

Country Patent Number Title Estimated Expiration
Germany 1468341 ⤷  Sign Up
Netherlands 6408512 ⤷  Sign Up
Brazil 6461109 ⤷  Sign Up
Switzerland 494730 Verfahren zur Herstellung von Dibenzocyclopentenen (Dibenzo cycloheptenes) ⤷  Sign Up
Belgium 650988 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.